Interferon (IFN)-β treatment enhances CD95 and interleukin 10 expression but reduces interferon-γ producing T cells in MS patients
- 1 April 1999
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 96 (1), 92-100
- https://doi.org/10.1016/s0165-5728(98)00271-9
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effects of an anti-IL-10 monoclonal antibody on rIFNβ-1b-mediated immune modulation. Relevance to multiple sclerosisJournal of Neuroimmunology, 1998
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- The Th1/Th2 balance in autoimmunityCurrent Opinion in Immunology, 1995
- Interferon effects on interleukin-10 secretion Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patientsJournal of Neuroimmunology, 1995
- The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosisAnnals of Neurology, 1995
- Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.The Journal of Experimental Medicine, 1995
- Immunotherapy for multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Biological properties of interleukin 10Immunology Today, 1992
- The role of IL-10 in crossregulation of TH1 and TH2 responsesImmunology Today, 1991
- CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSISThe Lancet, 1985